Skip to main content
Log in

The pharmacology of arachidonic acid-induced rat paw edema

  • Models of Inflammation and Arthritis
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Arachidonic acid (AA) injected into hindpaws of Lewis rats produces a severe edematous response. Treatment with corticosteroids (dexamethasone, prednisolone), dual inhibitors of arachidonate metabolism (phenidone, SK & F 86002), anti-histamine/serotonin agents (chlorpheniramine, cyproheptadine) and a gold compound (auranofin) inhibited AA-induced edema. In contrast, administration of high doses of cyclooxygenase inhibitors (indomethacin, piroxicam, naproxen, ibuprofen, meclofenamic acid and tiflamizole) did not affect AA-induced hind paw edema. The involvement of lipoxygenase products and mast cell mediators in the edematous response to arachidonic acid render this model potentially useful for studying antiinflammatory agents with a mechanism of action different from that of cyclooxygenase inhibitors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. E. M. Davidson,Leukotriene B 4,a mediator of inflammation present in synovial fluid in rheumatoid arthritis. Ann. Rheum. Dis.42, 677–679 (1983).

    PubMed  Google Scholar 

  2. J. T. O'Flaherty,Biology of disease, lipid mediators of inflammation and allergy. Lab. Invest.47, 314–329 (1982).

    PubMed  Google Scholar 

  3. J. M. Young, D. A. Spires, C. J. Bedford, B. Wagner, S. J. Ballaron and L. M. DeYoung,The mouse ear inflammatory response to topical arachidonic acid. J. Invest. Dermatol.82, 367–371 (1984).

    Article  PubMed  Google Scholar 

  4. R. P. Carlson, L. O'Neill-Davis, J. Chang and A. J. Lewis,Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents and Actions17, 197–204 (1985).

    Article  PubMed  Google Scholar 

  5. K. D. Rainsford,Comparison of the gastric ulcerogenic activity of new non-steroid antiinflammatory drugs in stressed rats. Br. J. Pharmacol.73, 226P-227P (1981).

    Google Scholar 

  6. G. J. Blackwell and R. J. Flower,1-Phenyl-3-pyrazolidone: An inhibitor of cyclic-oxygenase and lipoxygenase pathways in lung and platelets. Prostaglandins16, 417–425 (1978).

    Article  PubMed  Google Scholar 

  7. D. E. Griswold, P. J. Marshall, E. F. Webb, R. Godfrey, J. Newton, M. J. DiMartino, H. Sarau, J. Gleason, G. Poste and N. Hanna,SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid. Biochem. Pharmacol. In Press (1987).

  8. D. T. Walz, M. J. DiMartino, L. W. Chakrin, B. M. Sutton and A. Misher,Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: SK&F D-39162. J. Pharmacol. Exp. Therap.197, 142–152 (1976).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Mail Code: L-101

Rights and permissions

Reprints and permissions

About this article

Cite this article

DiMartino, M.J., Campbell, G.K., Wolff, C.E. et al. The pharmacology of arachidonic acid-induced rat paw edema. Agents and Actions 21, 303–305 (1987). https://doi.org/10.1007/BF01966498

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01966498

Keywords

Navigation